Dialogue Health Technologies Inc
TSX:CARE

Watchlist Manager
Dialogue Health Technologies Inc Logo
Dialogue Health Technologies Inc
TSX:CARE
Watchlist
Price: 5.14 CAD 0.1%
Market Cap: 346.7m CAD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

CARE Price Targets Summary
Dialogue Health Technologies Inc

There are no price targets for CARE.
CARE Lowest Forecast
Wall Street Target
Not Available
CARE Average Forecast
Wall Street Target
Not Available
CARE Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Dialogue Health Technologies Inc Competitors:
Price Targets
FLRY3
Fleury SA
5% Upside
ASTH
Apollo Medical Holdings Inc
63% Upside
4694
BML Inc
20% Upside
I
INFU
InfuSystem Holdings Inc
41% Upside
FLRY3
Fleury SA
5% Upside
ASTH
Apollo Medical Holdings Inc
63% Upside
4694
BML Inc
20% Upside
I
INFU
InfuSystem Holdings Inc
41% Upside
METROPOLIS
Metropolis Healthcare Ltd
9% Downside
KRSNAA
Krsnaa Diagnostics Ltd
27% Upside
DGX
Quest Diagnostics Inc
4% Upside
002044
Meinian Onehealth Healthcare Holdings Co Ltd
19% Upside

Revenue
Forecast

Revenue Estimate
Dialogue Health Technologies Inc

For the last 3 years the compound annual growth rate for Dialogue Health Technologies Inc's revenue is 105%. The projected CAGR for the next 3 years is 24%.

105%
Past Growth
24%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Dialogue Health Technologies Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Dialogue Health Technologies Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
CARE intrinsic value, competitors valuation, and company profile.
DCF Valuation
CARE stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CARE stock valuation using valuation multiples.
Wall Street Estimates
CARE price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CARE stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CARE's stock price target?
Not Available

CARE doesn't have any price targets made by Wall Street professionals.

What is Dialogue Health Technologies Inc's Revenue forecast?
Projected CAGR
24%

For the last 3 years the compound annual growth rate for Dialogue Health Technologies Inc's revenue is 105%. The projected CAGR for the next 3 years is 24%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 276,500+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.